Company Name: Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The company is engaged in the development and commercialization of drugs that target G protein-coupled receptors (GPCRs). The company’s first approved drug is a weight management product and its pipeline includes product candidates for conditions such as:

  • Ulcerative colitis
  • Pulmonary arterial hypertension (PAH)
  • Pain

Ticker Symbol: ARNA (NASDAQ)

Company Website: www.arenapharm.com

Social Media: Arena Pharmaceuticals LinkedIn Page    

Headquarters: San Diego, CA